Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

We retrospectively analyzed non-small cell lung cancer (NSCLC) patients from a single center treated with pembrolizumab on the KEYNOTE-001 trial and evaluated the association between treatment-related adverse events (trAEs) and clinical outcomes. Investigators reported AEs on trial and graded them a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Immunol Res
Main Authors: Lisberg, Aaron, Tucker, D. Andrew, Goldman, Jonathan W, Wolf, Brian, Carroll, James, Hardy, Ariana, Morris, Karolyn, Linares, Paulina, Adame, Carlos, Spiegel, Marshall L, Wells, Courtney, McKenzie, Jordan, Ledezma, Blanca, Mendenhall, Melody, Abarca, Phillip, Bornazyan, Krikor, Hunt, Jaime, Moghadam, Nima, Chong, Natalie, Nameth, Danielle, Marx, Caitlin, Madrigal, John, Vangala, Sitaram, Shaverdian, Narek, Elashoff, David, Garon, Edward B
פורמט: Artigo
שפה:Inglês
יצא לאור: 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066474/
https://ncbi.nlm.nih.gov/pubmed/29382669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0063
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים